FDA Grants Full Approval , to Pfizer-BioNTech’s , COVID-19 Vaccine.<br />The Food and Drug Administration (FDA) granted <br />full approval to the vaccine on Aug. 23.<br />The Food and Drug Administration (FDA) granted <br />full approval to the vaccine on Aug. 23.<br />It is the first vaccine in the U.S. to receive the designation since previously being authorized for emergency use.<br />According to the Centers for Disease Control and Prevention (CDC), .<br />over 204 million Pfizer shots have already been administered.<br />Pfizer and BioNTech applied for full approval for patients age 16 and up on May 7.<br />The FDA was under pressure from advocacy groups and the scientific community to fully approve the vaccine to promote confidence among Americans.<br />According to the agency, its scientists evaluated "hundreds of thousands of pages" of vaccine data.<br />According to acting FDA Commissioner <br />Janet Woodcock, the vaccine met their "high standards for safety, effectiveness and manufacturing quality.".<br />According to acting FDA Commissioner <br />Janet Woodcock, the vaccine met their "high standards for safety, effectiveness and manufacturing quality.".<br />While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated, Janet Woodcock, acting FDA Commissioner, via statement.<br />According to a survey from the Kaiser Family Foundation, <br />3 in 10 unvaccinated adults said they would be more <br />likely to get inoculated if a vaccine was fully approved.<br />The approval is also likely to increase the number of corporate vaccine mandates
